These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18690985)

  • 1. Efficacy and safety study of fixed-dose combination of ceftriaxone-vancomycin injection in patients with various infections.
    Chaudhary M; Shrivastava SM; Sehgal R
    Curr Drug Saf; 2008 Jan; 3(1):82-5. PubMed ID: 18690985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
    Plakogiannis R; Nogid A
    Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
    Blumer JL; Ghonghadze T; Cannavino C; O'Neal T; Jandourek A; Friedland HD; Bradley JS
    Pediatr Infect Dis J; 2016 Jul; 35(7):760-6. PubMed ID: 27078119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular enzyme elevations in a patient receiving ceftriaxone.
    Rivkin AM
    Am J Health Syst Pharm; 2005 Oct; 62(19):2006-10. PubMed ID: 16174837
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
    Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
    Yellin AE; Hassett JM; Fernandez A; Geib J; Adeyi B; Woods GL; Teppler H;
    Int J Antimicrob Agents; 2002 Sep; 20(3):165-73. PubMed ID: 12385694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-vancomycin drug toxicity reduction by VRP 1020 in Mus musculus mice.
    Soni A; Chaudhary M; Dwivedi VK
    Curr Clin Pharmacol; 2009 May; 4(2):95-101. PubMed ID: 19442074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
    Vetter N; Cambronero-Hernandez E; Rohlf J; Simon S; Carides A; Oliveria T; Isaacs R;
    Clin Ther; 2002 Nov; 24(11):1770-85. PubMed ID: 12501873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of ertapenem.
    Teppler H; Gesser RM; Friedland IR; Woods GL; Meibohm A; Herman G; Mistry G; Isaacs R
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii75-81. PubMed ID: 15150186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once daily ceftriaxone for central nervous system infections and other serious pediatric infections.
    Yogev R; Shulman ST; Chadwick EG; Davis AT; Glogowski W
    Pediatr Infect Dis; 1986; 5(3):298-303. PubMed ID: 3725639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery.
    Salminen US; Viljanen TU; Valtonen VV; Ikonen TE; Sahlman AE; Harjula AL
    J Antimicrob Chemother; 1999 Aug; 44(2):287-90. PubMed ID: 10473238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
    Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
    Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M;
    Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone: a third-generation cephalosporin.
    Nahata MC; Barson WJ
    Drug Intell Clin Pharm; 1985 Dec; 19(12):900-6. PubMed ID: 3910386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
    Legua P; Lema J; Moll J; Jiang Q; Woods G; Friedland I
    Clin Ther; 2002 Mar; 24(3):434-44. PubMed ID: 11952026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis.
    Congeni BL; Bradley J; Hammerschlag MR
    Pediatr Infect Dis; 1986; 5(3):293-7. PubMed ID: 3088548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.
    Breedt J; Teras J; Gardovskis J; Maritz FJ; Vaasna T; Ross DP; Gioud-Paquet M; Dartois N; Ellis-Grosse EJ; Loh E;
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4658-66. PubMed ID: 16251309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.